Screening of various leaf extracts of Chromolaena odorata L. for biochemical constituents and antimicrobial sensitivity
Keywords:
Antibacterial, Antifungal, Chromolaena odorata, Eupatorium odoratumAbstract
Background: Ethanolic, aqueous, petroleum ether and ethyl acetate extracts of leaves of Chromolaena odorata were studied for their antimicrobial activity. Twelve bacterial species, including six Gram-positive and six Gram-negative bacteria viz. Vibrio cholerae, Shigella sonnei, Klebsiella pneumoniae, Salmonella paratyphi A, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Staphylococcus citreus, methicillin-resistant S. aureus, nonpathogenic Mycobacterium gordonae and Mycobacterium fortuitum along with fungi Candida albicans and Aspergillus niger were studied.
Methods: This study involved antibiotic sensitivity testing of extracts against a wide spectrum of micro-organisms, to determine the antimicrobial activity of the plant.
Results: Initial phytochemical testing unveiled the chemical constituents of C. odorata as saponins, flavonoids, tannins, steroids and proteins. The zone of inhibition for the respective extracts was compared with the zone of the standard antibiotic and was found to be quite effective.
Conclusions: The ethanolic extract of C. odorata exhibited significant antimicrobial activity. The plant extracts could be used to treat resistant form of prevailing infections. Successful antimicrobial drugs can be developed out of these extracts if specific compounds are isolated and purified.
References
Hardman JG, Limbird LE, Gilman AG. General principles of antimicrobial therapy. In: Brunton LL, editor. The Pharmacological Basis of Therapeutics. 10th Edition. New York: McGraw-Hill; 2001: 707.
Iwu MM, Duncan AR, Okunji CO. New antimicrobials of plant origin. Perspectives on New Crops and New Uses. Alexandria: ASHS Press; 1999: 457-62.
Ebadi MS. Pharmacodynamic Basis of Herbal Medicine. 2nd Edition. New Delhi: CRC Press; 2007: 129-30.
Evan WC. Herbal medicine. Trease and Evans Pharmacognosy. 14th Edition. New York: WB Saunders Company Ltd.; 1997: 404.
Greenwood D, Finch R, Davey P, Wilcox M. Antimicrobial Chemotherapy. 5th Edition. Oxford: Oxford University Press; 2007: 5.
Woese CR. Bacterial evolution. Microbiol Rev. 1987;51(2):221-71.
Arias CA, Contreras GA, Murray BE. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect. 2010;16(6):555-62.
Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science. 1994;264(5157):375-82.
Boveé L, Whelan J, Sonder GJ, van Dam AP, van den Hoek A. Risk factors for secondary transmission of Shigella infection within households: implications for current prevention policy. BMC Infect Dis. 2012;12:347.
Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976-84.
Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997;40(1):135-6.
Zinderman CE, Conner B, Malakooti MA, LaMar JE, Armstrong A, Bohnker BK. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis. 2004;10(5):941-4.
Cabin Flaman A, Norris V, Den Blauwen T. The study of fungi & related forms. Microbiol Molecular Biol Rev. 2007;71(1):230-53.
King RM, Robinson H. Studies in the eupatorieae (Compositae). XXIX. The genus Chromolaena. Phytologia. 1970;20:196-209.
Kokate CK, Purohit AP, Gokhale SB. Pathway to screen phytochemical nature of natural drugs. Pharmacognosy. 34th Edition. Pune: Nirali Prakashan; 2006: 593-7.
